Plain-English translation of NCT04263285 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called repetitive transcranial magnetic stimulation (rTMS) for people with depression and spinal cord injury. rTMS is a non-invasive procedure that uses magnetic pulses to stimulate parts of the brain. The study will check whether this treatment is safe and whether it can reduce depression symptoms in people with spinal cord injury.
Depression is much more common in people with spinal cord injury than in the general population, but doctors don't yet know the best way to treat it. This trial exists to see if this magnetic brain stimulation approach could be a helpful new option for people struggling with depression after spinal cord injury.
You likely qualify if…
You likely don't qualify if…
You would receive the magnetic brain stimulation treatment five days a week for four weeks. The treatment itself is non-invasive — a magnetic coil is placed against your scalp, and you remain awake during the procedure. After the four-week treatment period, the study team will check how safe the treatment was and measure any changes in your depression symptoms using standard questionnaires.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
United States